ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,542Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 1171

$1.44M Total Retail Price of All Prescriptions

Rank: 17 out of 1171

1,190 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 1,190 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 1,190 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

3% of this provider’s 23,729 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
LEVOTHYROXINE SODIUM 1,367 1,189 1 4
SIMVASTATIN 1,112 984 2 1
HYDROCODONE-ACETAMINOPHEN 1,046 784 S3 3 8
AMLODIPINE BESYLATE 946 849 4 2
LISINOPRIL 873 750 5 3
OMEPRAZOLE 869 705 6 5
HYDROCHLOROTHIAZIDE 768 706 7 9
FUROSEMIDE 666 597 8 6
METOPROLOL TARTRATE 659 603 9 11
METFORMIN HCL 546 429 10 7
GLIMEPIRIDE 494 467 11 34
POTASSIUM CHLORIDE 415 351 12 19
LOSARTAN POTASSIUM 390 363 13 14
SERTRALINE HCL 348 321 14 23
METOPROLOL SUCCINATE 343 301 15 17
ATORVASTATIN CALCIUM 302 269 16 10
RANITIDINE HCL 297 284 17 38
CITALOPRAM HBR 285 218 18 22
ATENOLOL 279 222 19 15
ALENDRONATE SODIUM 277 265 20 33
SYNTHROID 271 205 21 48
FLUTICASONE PROPIONATE 271 229 21 30
FAMOTIDINE 265 218 23 75
PANTOPRAZOLE SODIUM 258 205 24 29
TRAMADOL HCL 253 185 25 18
CLOPIDOGREL 249 226 26 35
WARFARIN SODIUM 246 211 27 12
ALPRAZOLAM 225 213 28 184
BENAZEPRIL HCL 210 190 29 83
DOXYCYCLINE HYCLATE 208 172 30 137
CEFUROXIME 206 182 31 169
PRAVASTATIN SODIUM 205 181 32 13
NEXIUM 205 180 32 25
RAMIPRIL 205 194 32 85
ISOSORBIDE MONONITRATE ER 196 173 35 44
AZITHROMYCIN 189 156 36 43
DONEPEZIL HCL 185 185 37 24
KLOR-CON M20 176 162 38 41
ZOLPIDEM TARTRATE 176 131 38 21
MELOXICAM 175 159 40 56
AMITRIPTYLINE HCL 161 144 R 41 74
PLAVIX 161 152 41 55
PROAIR HFA 154 128 43 49
CARVEDILOL 152 145 44 20
CIPROFLOXACIN HCL 148 128 45 61
GABAPENTIN 129 96 46 16
NAMENDA 127 127 47 42
MIRTAZAPINE 126 113 48 50
METHOCARBAMOL 118 89 R 49 274
PAROXETINE HCL 116 79 50 62
TRAZODONE HCL 113 101 51 37
BENICAR 111 107 52 181
AMOXICILLIN 110 82 53 111
ALLOPURINOL 106 97 54 31
PREDNISONE 104 69 55 39
CYCLOBENZAPRINE HCL 103 78 R 56 67
GLIPIZIDE ER 102 94 57 86
ZETIA 101 88 58 63
BUSPIRONE HCL 94 82 59 129
DIOVAN 90 72 60 32
PROPRANOLOL HCL 90 74 60 134
AGGRENOX 89 82 62 148
TOPROL XL 88 88 63 324
LOVASTATIN 87 84 64 36
SPIRIVA 87 84 64 57
TRIAMCINOLONE ACETONIDE 84 74 66 133
PROMETHAZINE HCL 82 50 R 67 87
ENALAPRIL MALEATE 81 68 68 73
DIGOXIN 79 79 69 68
CEFDINIR 77 63 70 197
ADVAIR DISKUS 76 74 71 51
TRIMETHOPRIM 75 74 72 297
DICLOFENAC SODIUM 75 60 72 103
PREMARIN 74 54 R 74 237
NYSTATIN 74 65 74 128
QUETIAPINE FUMARATE 74 72 74 54
QUINAPRIL HCL 73 73 77 156
CEPHALEXIN 72 53 78 104
IBUPROFEN 72 60 78 80
LANTUS SOLOSTAR 71 56 80 90
LIPITOR 70 63 81 92
FENOFIBRATE 70 65 81 81
EXELON 69 69 83 164
MECLIZINE HCL 69 63 83 115
DOXAZOSIN MESYLATE 68 68 85 82
LANTUS 68 64 85 46
HYDRALAZINE HCL 66 66 87 60
INSULIN SYRINGE 64 61 88 71
LOVAZA 64 63 88 118
ESCITALOPRAM OXALATE 64 54 88 69
VENLAFAXINE HCL ER 62 58 91 113
GLYBURIDE 62 50 R 91 97
FENTANYL 61 40 S2 93 89
MUPIROCIN 60 49 94 231
EVISTA 60 53 94 154
VERAPAMIL ER 59 50 96 91
CYMBALTA 59 30 96 64
NABUMETONE 59 53 96 201
CRESTOR 58 45 99 27
LYRICA 58 55 99 127
TRIAMTERENE-HCTZ 58 50 99 58
ACTOS 57 57 102 123
SOTALOL 57 57 102 294
JANUVIA 56 52 104 66
GLIPIZIDE 55 32 105 47
CLONIDINE HCL 55 42 105 45
DILTIAZEM 24HR CD 55 50 105 101
TORSEMIDE 54 48 108 150
TRICOR 54 42 108 140
OXYBUTYNIN CHLORIDE ER 53 41 110 135
ACTONEL 53 53 110 212
OXYCODONE HCL 52 27 S2 112 79
LACTULOSE 52 52 112 108
LISINOPRIL-HYDROCHLOROTHIAZIDE 50 33 114 26
ISOSORBIDE DINITRATE 50 50 114 213
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 11, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.